Effects of Intensive Rehabilitation after Botulinum Toxin Type A Injection on Gait in Chronic Post-Stroke Patients

Effects of Intensive Rehabilitation after Botulinum Toxin Type A Injection on Gait in Chronic Post-Stroke Patients - Effects of Rehabilitation after Botulinum Toxin Type A Injection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023092

Enrollment

Registered

2016-07-10

Start date

2016-07-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: post-stroke hemiparesis, lower-limb spasticity causing gait disturbance, 6 months or more after stroke onset, spastic drop foot by a score of 2 or more for ankle flexors on the modified Ashworth scale, no history of BoNT-A injection for lower-limb spasticity, gait assessed by functional independence measure score 5 or more.

Exclusion criteria

Exclusion criteria: No remarkable higher brain dysfunction affecting gait disturbance.

Design outcomes

Primary

Measure	Time frame
The modified Ashworth scale of ankle plantar flexor, range of motion of ankle dorsiflexion, 10-meter walking test, 6-minute walking distance test, timed up and go test, and Berg balance scale at every 2-week follow-up after BoNT-A injection.	—

Countries

Japan

Contacts

Public ContactYuki Uchiyama

Hyogo Medical University Department of Rehabilitation Medicine

yutti@hyo-med.ac.jp0798-45-6881

Outcome results